Is a complete TARS research report available?

No complete published report is available for Tarsus Pharmaceuticals, Inc. (TARS) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

Tarsus Pharmaceuticals, Inc. (TARS)

NASDAQ: TARS · USD

$72.0

+1.26 (+1.8%)· Recorded snapshot

Market cap	3.2B
Revenue (ttm)	606.3M
Net income (ttm)	-46.5M
EPS (ttm)	-$1.08
Shares out	43.9M
Volume	303,716
Beta	0.45

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 606.3M
Net income (ttm): -46.5M
EPS (ttm): -$1.08
Market cap: 3.2B

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
EXAS	Exact Sciences Corp	—	—	—	—	—	—	Conserver

Metric	Value
Amount currency	USD
CIK code	0001819790
Company name	Tarsus Pharmaceuticals, Inc.
Country	United States
Country code	US
CUSIP number	87650L103
Earnings date	2026-11-10
Earnings time	amc
Employees	370
Employees change	47
Employees growth	14.55%
Enterprise value	$2.8B
Exchange	NASDAQ
Financial currency	USD
Financial report date	2026-06-30
First seen	2026-05-09
Fiscal year end	December
Founded	2016
In index	RUSSELL2000
Industry	Biotechnology
IPO date	2020-10-16
Is primary listing	Yes
Is SPAC	No
ISIN number	US87650L1035
Last 10-K release date	2026-02-23
Last earnings date	2026-08-06
Last refreshed	2026-10-28
Last stock split type	Never
Market cap	$3.2B
Market cap category	Mid-Cap
Next earnings date	2026-11-10
Options	Yes
Price	$72.02
Price currency	USD
Sector	Healthcare
SIC code	2836
Stock price date	2026-10-28
Symbol	TARS
U.S. state	California
Website	https://tarsusrx.com

Metric

Value

Amount currency

USD

CIK code

0001819790

Company name

Tarsus Pharmaceuticals, Inc.

Country

United States

Country code

CUSIP number

87650L103

Earnings date

2026-11-10

Earnings time

amc

Employees

370

Employees change

Employees growth

14.55%

Enterprise value

$2.8B

Exchange

NASDAQ

Financial currency

USD

Financial report date

2026-06-30

First seen

2026-05-09

Fiscal year end

December

Founded

2016

In index

RUSSELL2000

Industry

Biotechnology

IPO date

2020-10-16

Is primary listing

Yes

Is SPAC

ISIN number

US87650L1035

Last 10-K release date

2026-02-23

Last earnings date

2026-08-06

Last refreshed

2026-10-28

Last stock split type

Never

Market cap

$3.2B

Market cap category

Mid-Cap

Next earnings date

2026-11-10

Options

Yes

Price

$72.02

Price currency

USD

Sector

Healthcare

SIC code

2836

Stock price date

2026-10-28

Symbol

TARS

U.S. state

California

Website

https://tarsusrx.com

Metric	Value
Earnings yield	-1.5%
EV/FCF	49.64x
EV/Sales	4.59x
FCF / EV yield	2.01%
FCF yield	1.78%
Forward EV/Sales	3.36x
Forward P/S	3.8x
P/(FCF - SBC) ratio	749.68x
P/(OCF - SBC) ratio	140.57x
P/B ratio	8.83x
P/FCF ratio	56.09x
P/OCF ratio	42.36x
P/S ratio	5.18x
Price / tangible book value	9.24x
Sector forward P/E	23.56x
Sector P/E	50.13x

Metric

Value

Earnings yield

-1.5%

EV/FCF

49.64x

EV/Sales

4.59x

FCF / EV yield

2.01%

FCF yield

1.78%

Forward EV/Sales

3.36x

Forward P/S

3.8x

P/(FCF - SBC) ratio

749.68x

P/(OCF - SBC) ratio

140.57x

P/B ratio

8.83x

P/FCF ratio

56.09x

P/OCF ratio

42.36x

P/S ratio

5.18x

Price / tangible book value

9.24x

Sector forward P/E

23.56x

Sector P/E

50.13x

Metric	Value
EBIT margin	-8%
EBITDA margin	-7.62%
FCF margin	9.24%
Gross margin	82.67%
Operating margin	-8%
Pretax margin	-6.49%
Profit margin	-7.67%
Profit per employee	$-125,611
Revenue per employee	$1.6M
ROA	-5.48%
ROA (5Y)	-18.56%
ROCE	-11.15%
ROE	-13.68%
ROE (5Y)	-38.15%
ROIC	-7.22%
SBC / revenue	8.55%
Tax / revenue	1.18%

Metric

Value

EBIT margin

-8%

EBITDA margin

-7.62%

FCF margin

9.24%

Gross margin

82.67%

Operating margin

-8%

Pretax margin

-6.49%

Profit margin

-7.67%

Profit per employee

$-125,611

Revenue per employee

$1.6M

ROA

-5.48%

ROA (5Y)

-18.56%

ROCE

-11.15%

ROE

-13.68%

ROE (5Y)

-38.15%

ROIC

-7.22%

SBC / revenue

8.55%

Tax / revenue

1.18%

Metric	Value
EPS growth quarters	9
EPS growth years	2
Gross profit growth	103.02%
Gross profit growth (Q)	67.8%
Gross profit growth 5Y	103.47%
Net income growth quarters	8
Net income growth years	2
Revenue growth	105.17%
Revenue growth (Q)	69.41%
Revenue growth (QoQ)	7.32%
Revenue growth 3Y	264.7%
Revenue growth 5Y	61.35%
Revenue growth quarters	8
Revenue growth years	2

Metric

Value

EPS growth quarters

EPS growth years

Gross profit growth

103.02%

Gross profit growth (Q)

67.8%

Gross profit growth 5Y

103.47%

Net income growth quarters

Net income growth years

Revenue growth

105.17%

Revenue growth (Q)

69.41%

Revenue growth (QoQ)

7.32%

Revenue growth 3Y

264.7%

Revenue growth 5Y

61.35%

Revenue growth quarters

Revenue growth years

Metric	Value
Capital expenditures	$-18.2M
Depreciation and amortization	$2.3M
EBIT	$-48.5M
EBITDA	$-46.2M
EPS	$-1.08
FCF per share	$1.28
Financing cash flow	$9.4M
Free cash flow	$56M
Free cash flow minus SBC	$4.2M
Gross profit	$501.3M
Income taxes	$7.1M
Investing cash flow	$23.8M
Net cash flow	$107.4M
Net income	$-46.5M
Operating cash flow minus SBC	$22.3M
Operating income	$-48.5M
Revenue	$606.3M
Stock-based compensation	$51.8M

Metric

Value

Capital expenditures

$-18.2M

Depreciation and amortization

$2.3M

EBIT

$-48.5M

EBITDA

$-46.2M

EPS

$-1.08

FCF per share

$1.28

Financing cash flow

$9.4M

Free cash flow

$56M

Free cash flow minus SBC

$4.2M

Gross profit

$501.3M

Income taxes

$7.1M

Investing cash flow

$23.8M

Net cash flow

$107.4M

Net income

$-46.5M

Operating cash flow minus SBC

$22.3M

Operating income

$-48.5M

Revenue

$606.3M

Stock-based compensation

$51.8M

Metric	Value
Altman Z-Score	6.66
Book value per share	$8.01
Debt / equity	0.26
Debt / FCF	1.59
Interest coverage	-5.54
Long-term assets	$49.2M
Long-term liabilities	$88.7M
Net cash (debt)	$360.9M
Net cash / market cap	11.49%
Net cash growth	16.9%
Net debt / equity	-1.04
Net debt / FCF	-6.44
Piotroski F-Score	3
Property, plant and equipment	$30.4M
Shareholders' equity	$346.7M
Tangible book value	$339.8M
Tangible book value per share	$7.85
Total assets	$611.1M
Total cash	$449.7M
Total debt	$88.8M
Total liabilities	$264.4M
WACC	6.73%

Metric

Value

Altman Z-Score

6.66

Book value per share

$8.01

Debt / equity

0.26

Debt / FCF

1.59

Interest coverage

-5.54

Long-term assets

$49.2M

Long-term liabilities

$88.7M

Net cash (debt)

$360.9M

Net cash / market cap

11.49%

Net cash growth

16.9%

Net debt / equity

-1.04

Net debt / FCF

-6.44

Piotroski F-Score

Property, plant and equipment

$30.4M

Shareholders' equity

$346.7M

Tangible book value

$339.8M

Tangible book value per share

$7.85

Total assets

$611.1M

Total cash

$449.7M

Total debt

$88.8M

Total liabilities

$264.4M

WACC

6.73%

Metric	Value
Asset turnover	1.1
Current assets	$562M
Current liabilities	$175.8M
Current ratio	3.2
Inventory turnover	25.47
Net working capital	$-63.3M
Quick ratio	3.12
Working capital	$386.2M
Working capital turnover	1.57

Metric

Value

Asset turnover

1.1

Current assets

$562M

Current liabilities

$175.8M

Current ratio

3.2

Inventory turnover

25.47

Net working capital

$-63.3M

Quick ratio

3.12

Working capital

$386.2M

Working capital turnover

1.57

Metric	Value
Buyback yield / dilution	-7.95%
Dividend yield	0%
Shareholder yield	-7.95%

Metric

Value

Buyback yield / dilution

-7.95%

Dividend yield

Shareholder yield

-7.95%

Metric	Value
150-day SMA	$67.43
1D price change	1.78%
1M price change	-5.15%
1M total return	-5.15%
1W price change	1.07%
1W total return	1.07%
1Y price change	5.32%
1Y return CAGR	5.32%
1Y total return	5.32%
20-day SMA	$71.82
200-day SMA	$67.79
3M price change	19.41%
3M total return	19.41%
3Y price change	421.73%
3Y return CAGR	73.42%
3Y total return	421.73%
50-day SMA	$75.07
50-day SMA vs 200-day SMA	50over200
52-week high	$91.53
52-week high date	2026-09-04
52-week low	$53.89
52-week low date	2026-07-15
5Y price change	160.68%
5Y return CAGR	21.12%
5Y total return	160.68%
6M price change	17.82%
6M total return	17.82%
All-time high	$91.53
All-time high date	2026-09-04
All-time low	$10.80
All-time low date	2022-05-09
Average true range (ATR)	$3.22
Average volume	980.4K
Beta (1Y)	0.23
Beta (2Y)	0.24
Beta (5Y)	0.45
Change from 52-week high	-21.32%
Change from 52-week low	33.64%
Change from all-time high	-21.57%
Change from all-time low	564.72%
Change from open	2.3%
Day's gap	-0.51%
Dollar volume	$21.9M
High price	$72.16
Low price	$70.40
Monthly RSI	58.01
Open price	$70.40
Position in 52-week range	92.05%
Premarket change	1.03%
Premarket close	$70.76
Premarket price	$71.49
Premarket volume	1.9K
Previous close	$70.76
Price vs 150-day SMA	6.46%
Price vs 20-day SMA	-0.05%
Price vs 200-day SMA	5.9%
Price vs 50-day SMA	-4.37%
Relative volume	0.31
Return from IPO open	341.85%
Return from IPO price	347.38%
RSI	48.53
Sharpe ratio	0.25
Sharpe ratio (3Y)	1.27
Sharpe ratio (5Y)	0.54
Sortino ratio	0.51
Sortino ratio (3Y)	2.2
Sortino ratio (5Y)	0.91
Volume	303.7K
Weekly RSI	52.43
YTD price change	-12.32%
YTD total return	-12.32%

Metric

Value

150-day SMA

$67.43

1D price change

1.78%

1M price change

-5.15%

1M total return

-5.15%

1W price change

1.07%

1W total return

1.07%

1Y price change

5.32%

1Y return CAGR

5.32%

1Y total return

5.32%

20-day SMA

$71.82

200-day SMA

$67.79

3M price change

19.41%

3M total return

19.41%

3Y price change

421.73%

3Y return CAGR

73.42%

3Y total return

421.73%

50-day SMA

$75.07

50-day SMA vs 200-day SMA

50over200

52-week high

$91.53

52-week high date

2026-09-04

52-week low

$53.89

52-week low date

2026-07-15

5Y price change

160.68%

5Y return CAGR

21.12%

5Y total return

160.68%

6M price change

17.82%

6M total return

17.82%

All-time high

$91.53

All-time high date

2026-09-04

All-time low

$10.80

All-time low date

2022-05-09

Average true range (ATR)

$3.22

Average volume

980.4K

Beta (1Y)

0.23

Beta (2Y)

0.24

Beta (5Y)

0.45

Change from 52-week high

-21.32%

Change from 52-week low

33.64%

Change from all-time high

-21.57%

Change from all-time low

564.72%

Change from open

2.3%

Day's gap

-0.51%

Dollar volume

$21.9M

High price

$72.16

Low price

$70.40

Monthly RSI

58.01

Open price

$70.40

Position in 52-week range

92.05%

Premarket change

1.03%

Premarket close

$70.76

Premarket price

$71.49

Premarket volume

1.9K

Previous close

$70.76

Price vs 150-day SMA

6.46%

Price vs 20-day SMA

-0.05%

Price vs 200-day SMA

5.9%

Price vs 50-day SMA

-4.37%

Relative volume

0.31

Return from IPO open

341.85%

Return from IPO price

347.38%

RSI

48.53

Sharpe ratio

0.25

Sharpe ratio (3Y)

1.27

Sharpe ratio (5Y)

0.54

Sortino ratio

0.51

Sortino ratio (3Y)

2.2

Sortino ratio (5Y)

0.91

Volume

303.7K

Weekly RSI

52.43

YTD price change

-12.32%

YTD total return

-12.32%

Metric	Value
Float	32.7M
Float percentage	74.61%
Shares change (QoQ)	1.02%
Shares change (YoY)	7.95%
Shares held by insiders	3.06%
Shares held by institutions	88.62%
Shares outstanding	43.9M
Short % of float	17.51%
Short % of shares	13.06%
Short ratio	7.3 days

Metric

Value

Float

32.7M

Float percentage

74.61%

Shares change (QoQ)

1.02%

Shares change (YoY)

7.95%

Shares held by insiders

3.06%

Shares held by institutions

88.62%

Shares outstanding

43.9M

Short % of float

17.51%

Short % of shares

13.06%

Short ratio

7.3 days

Tarsus Pharmaceuticals, Inc. (TARS)

Price

Financial snapshot

Fair-value bridge

Latest news · TARS

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All TARS indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on TARS

Frequently asked questions